Silibinin ameliorates LPS-induced memory deficits in experimental animals

Neurobiology of Learning and Memory

Volumn 116, Issue , 2014, Pages 117-131

  Joshi, Ritu ^a   Garabadu, Debapriya ^a   Teja, Gangineni Ravi ^a   Krishnamurthy, Sairam ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Acetylcholine; A ; LPS; Memory; Neuroinflammation; Silibinin

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; SILIBININ; SUPEROXIDE DISMUTASE; ANTIOXIDANT; SILYMARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DOSE RESPONSE; ELEVATED PLUS MAZE TEST; ENZYME ACTIVITY; EXPERIMENTAL ANIMAL; HIPPOCAMPUS; LATERAL BRAIN VENTRICLE; LIPID PEROXIDATION; LONG TERM MEMORY; MALE; MEMORY; MEMORY DISORDER; MITOCHONDRION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PREFRONTAL CORTEX; RAT; WORKING MEMORY; Y-MAZE TEST; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; MAZE TEST; MEMORY DISORDERS; METABOLISM; WISTAR RAT;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANIMALS; ANTIOXIDANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; LIPOPOLYSACCHARIDES; MALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; RATS; RATS, WISTAR; SILYMARIN;

EID: 84910106257     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2014.09.006     Document Type: Article

References (95)

1. Baluchnejadmojarada T., Roghanib M., Mafakheri M. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: Involvement of estrogen receptors and oxidative stress. Neuroscience Letters 2010, 480:206-210.
2. Blennow K., de Leon M.J., Zetterberg H. Alzheimer's disease. Lancet 2006, 368:387-403.
3. Bluthe R.M., Dantzer R., Kelley K.W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Research 1992, 573:318-320.
4. Bluthe R.M., Laye S., Michaud B., Combe C., Dantzer R., Parnet P. Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: A study with interleukin-1 type I receptor-deficient mice. European Journal of Neuroscience 2000, 12:4447-4456.
5. Borovikova L.V., Ivanova S., Zhang M., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248-254.
7. Bronstein P.M. Open {Thorn}eld behaviour of the rat as a function of age: Cross sectional and longitudinal investigations. Journal of Component Physiology and Psychology 1972, 80:335-341.
8. Buxbaum J.D., Oishi M., Chen H.I., Pinkas-Kramarski R., Jaffe E.A., Gandy S.E., et al. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proceedings of National Academy of Science USA 1992, 89(21):10075-10078.
9. Castellani R.J., Zhu X., Lee H.G., Moreira P.I., Perry G., Smith M.A. Neuropathology and treatment of Alzheimer disease: Did we lose the forest for the trees?. Expert Review of Neurotherapeutics 2007, 7:473-485.
10. Chen Z.J., Parent L., Maniatis T. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell 1996, 84:853-862.
11. Choi D.Y., Lee J.W., Lin G., Lee Y.K., Lee Y.H., Choi I.S., et al. Obovatol attenuates LPS-induced memory impairments in mice via inhibition of NF-κB signaling pathway. Neurochemistry International 2012, 60(1):68-77.
12. Chuang Y.C., Tsai J.L., Chang A.Y., Chan J.Y., Liou C.W., Chan S.H. Dysfunction of the mitochondrial respiratory chain in the rostral ventrolateral medulla during experimental endotoxemia in the rat. Journal of Biomedical Science 2002, 9(6 Pt 1):542-548.
13. Corral-Debrinski M., Shoffner J.M., Lott M.T., Wallace D.C. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutation Research 1992, 275(3-6):169-180.
14. Diana A., Simić G., Sinforiani E., Orrù N., Pichiri G., Bono G. Mitochondria morphology and DNA content upon sublethal exposure to beta-amyloid(1-42) peptide. Collegium of Antropology 2008, 32(Suppl 1):51-58.
15. Ding T., Tian S., Zhang Z., Gu D., Chen Y., Shi Y., et al. Determination of active component in silymarin by RP-LC and LC/MS. Journal of Pharmceutical and Biomedical Analysis 2001, 26:155-161.
16. Ferri C.P., Sousa R., Albanese E., Ribeiro W.S., Honyashiki M. World alzheimer report 2009-executive summary 2009, 1-22. Alzheimer's Disease International, London. M. Prince, J. Jackson (Eds.).
17. Fiske C.H., Subbarao Y. The colorimetric determination of phosphorus. Journal of Biological Chemistry 1925, 66:375-400.
18. Forster M.J., Dubey A., Dawson K.M., Stutts W.A., Lal H., Sohal R.S. Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proceedings of National of Academy Science USA 1996, 93(10):4765-4769.
19. Frenois F., Moreau M., O'Connor J., Lawson M., Micon C., Lestage J., et al. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 2007, 32:516-531.
20. Garabadu D., Krishnamurthy S. Diazepam potentiates the anti-diabetic, anti-stress and anxiolytic activities of metformin in type-2 diabetes mellitus with co-occurring stress in experimental animals. Biomedical Research of International 2014, Article ID 693074, 15 pages. 10.1155/2014/693074.
21. Garabadu D., Krishnamurthy S. Temporal effect of repeated stress on type-2 experimental diabetes. Diabetes mellitus and human health care - A holistic approach to diagnosis and treatment 2013, 357-392. Apple Academic Press Inc., USA. M.D. Anne George, R. Augustine, M.D. Mathew Sebastian (Eds.).
22. + injection in rats. Pharmacology, Biochemistry and Behavior 2014, 117:92-103.
23. Godbout J.P., Chen J., Abraham J., Richwine A.F., Berg B.M., Kelly K.W., et al. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. The FASEB Journal 2005, 19:1329-1331.
24. Gong Q.H., Wang Q., Pan L.L., Liu X.H., Huang H., Zhu Y.Z. Hydrogen sulfide attenuates lipopolysaccharide-induced cognitive impairment: A pro-inflammatory pathway in rats. Pharmacology, Biochemistry and Behavior 2010, 96(1):52-58.
25. Gong Q.H., Wang Q., Pan L.L., Liu X.H., Xin H., Zhu Y.Z. S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuates lipopolysaccharide-induced spatial learning and memory impairment: Involvement of TNF signaling and NF-κB pathway in rats. Brain, Behavior, and Immunity 2011, 25(1):110-119.
26. 15N] nitrate in biological fluids. Analytical Biochemistry 1982, 126:131-138.
27. Griffiths D.E., Houghton R.L. Studies on energy linked reactions: Modified mitochondrial ATPase of oligomycin-resistant mutants of Saccharomyces cerevisiae. European Journal of Biochemistry 1974, 46:157-167.
28. Guo J.T., Yu J., Grass D., de Beer F.C., Kindy M.S. Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. Journal of Neuroscience 2002, 22:5900-5909.
29. Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nature Reviews Molecular Cell Biology 2007, 8:101-112.
30. Haba R., Shintani N., Onaka Y., Wang H., Takenaga R., Hayata A., et al. Lipopolysaccharide affects exploratory behaviors toward novel objects by impairing cognition and/or motivation in mice. Possible role of activation of the central amygdala. Behavioural Brain Research 2012, 228:423-431.
31. Hang C.H., Shi J.X., Tian J., Li J.S., Wu W., Yin H.X. Effect of systemic LPS injection on cortical NF-kappaB activity and inflammatory response following traumatic brain injury in rats. Brain Research 2004, 1026:23-32.
32. Henry C.J., Huang Y., Wynne A., Hanke M., Himler J., Bailey M.T., et al. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. Journal of Neuroinflammation 2008, 5:15.
33. Hritcu L., Gorgan L.D. Intranigral lipopolysaccharide induced anxiety and depression by altered BDNF mRNA expression in rat hippocampus. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2014, 51:126-132.
34. Huang S.G. Development of a high throughput screening assay for mitochondrial membrane potential in living cells. Journal of Biomolecular Screening 2002, 7:383-389.
35. Hwang D.Y., Chae K.R., Kang T.S., Hwang J.H., Lim C.H., Kang H.K., et al. Alterations in behavior, amyloid beta-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease. The FASEB Journal 2002, 16:805-813.
36. Itoh J., Nabeshima T., Kameyama T. Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice. European Journal of Pharmacology 1991, 194:71-76.
37. Jain A., Yadav A., Bozhkov A.I., Padalko V.I., Flora S.J. Therapeutic efficacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats. Ecotoxicology and Environmental Safety 2011, 74(4):607-614.
38. Kakkar P., Das B., Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Indian Journal of Biochemistry and Biophysics 1984, 21:130-132.
39. Kalb A., von Haefen C., Sifringer M., Tegethoff A., Paeschke N., Kostova M., et al. Acetylcholinesterase inhibitors reduce neuroinflammation and -degeneration in the cortex and hippocampus of a surgery stress rat model. PLoS ONE 2013, 8:e62679.
40. Kamboj S.S., Kumar V., Kamboj A., Sandhir R. Mitochondrial oxidative stress and dysfunction in rat brain induced by carbofuran exposure. Cellular and Molecular Neurobiology 2008, 28(7):961-969.
41. Ko C.Y., Chang L.H., Lee Y.C., Sterneck E., Cheng C.P., Chen S.H., et al. CCAAT/enhancer binding protein delta (CEBPD) elevating PTX3 expression inhibits macrophage-mediated phagocytosis of dying neuron cells. Neurobiology of Aging 2012, 33(2). 422 e11-25.
42. Kren V., Walterova D. Silybin and silymarin - New effects and applications. Biomedical Papers of the Medical Faculty of the University of Palacky Olomouc Czech Republic 2005, 149:29-41.
43. Labak M., Foniok T., Kirk D., Rushforth D., Tomanek B., Jasiński A., et al. Metabolic changes in rat brain following intracerebroventricular injections of streptozotocin: A model of sporadic Alzheimer's disease. Acta Neurochirurgica. Supplementum 2010, 106:177-181.
44. Lee Y.J., Han S.B., Nam S.Y., Oh K.W., Hong J.T. Inflammation and Alzheimer's disease. Archives of Pharmacal Research 2010, 33:1539-1556.
45. Lee Y.K., Yuk D.Y., Lee J.W., Lee S.Y., Ha T.Y., Oh K.W., et al. (-)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency. Brain Research 2008, 1250:164-174.
46. Lin M.S., Sun Y.Y., Chiu W.T., Hung C.C., Chang C.Y., Shie F.S., et al. Curcumin attenuates the expression and secretion of RANTES after spinal cord injury in vivo and lipopolysaccharide-induced astrocyte reactivation in vitro. Journal of Neurotrauma 2011, 28(7):1259-1269.
47. Liu X., Wu Z., Hayashi Y., Nakanishi H. Age-Dependent neuroinflammatory responses and deficits in long-term potentiation in the hippocampus during systemic inflammation. Neuroscience 2012, 216:133-142.
48. Lowry O.H., Rosenborough N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
49. Lu P., Mamiya T., Lu L., Mouri A., Niwa M., Kim H.C., et al. Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment. Behavioural Brain Research 2010, 207:387-393.
50. Mandillo S., Tucci V., Hölter S.M., Meziane H., Banchaabouchi M.A., Kallnik M., et al. Reliability, robustness, and reproducibility in mouse behavioral phenotyping: A cross-laboratory study. Physiological Genomics 2008, 34(3):243-255.
51. Marrazzo G., Bosco P., La Delia F., Scapagnini G., Di Giacomo C., Malaguarnera M., et al. Neuroprotective effect of silibinin in diabetic mice. Neuroscience Letters 2011, 504:252-256.
52. Mattson M.P., Maudsley S., Martin B. A neural signaling triumvirate that influences ageing and age-related disease: Insulin/IGF-1, BDNF and serotonin. Ageing Research Reviews 2004, 3:445-464.
53. McGeer E.G., McGeer P.L. Inflammatory processes in Alzheimer's disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2003, 27:741-749.
54. McGeer P.L., Rogers J. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 1992, 42:447-449.
55. Morazzoni P., Bombardelli E. Silybum marianum (Carduus marianus). Fitoterapia 1995, 66:3-42.
56. Moreira P.I., Santos M.S., Sena C., Seiça R., Oliveira C.R. Insulin protects against amyloid beta-peptide toxicity in brain mitochondria of diabetic rats. Neurobiology of Diseases 2005, 18:628-637.
57. Mouri A., Noda Y., Hara H., Mizoguchi H., Tabira T., Nabeshima T. Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model. The FASEB Journal 2007, 21(9):2135-2148.
58. Muthuraju S., Maiti P., Solanki P., Sharma A.K., Amitabh Singh S.B., Prasad D., et al. Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia. Behavioural Brain Research 2009, 203(1):1-14.
59. Nakahira K., Haspel J.A., Rathinam V.A., Lee S.J., Dolinay T., Lam H.C., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nature Immunology 2011, 12(3):222-230.
60. Nathan C. Points of control in inflammation. Nature 2002, 420:846-852.
61. Navarro A., Sánchez Del Pino M.J., Gómez C., Peralta J.L., Boveris A. Behavioral dysfunction, brain oxidative stress, and impaired mitochondrial electron transfer in aging mice. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 2002, 282(4):R985-R992.
62. Nizri E., Amitay Y.H., Sicsic C., Lavon I., Brenner T. Antiinflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors. Neuropharmacology 2006, 50:540-547.
63. Noble F., Rubira E., Boulanouar M., Palmier B., Plotkine M., Warnet J.M., et al. Acute systemic inflammation induces central mitochondrial damage and mnesic deficit in adult Swiss mice. Neuroscience Letters 2007, 424(2):106-110.
64. Obregon D.F., Rezai-Zadeh K., Bai Y., Sun N., Hou H., Ehrhart J., et al. ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein. Journal of Biological Chemistry 2006, 281:16419-16427.
65. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979, 95:351-358.
66. Ojha R., Sahu A.N., Muruganandam A.V., Singh G.K., Krishnamurthy S. Asparagus recemosus enhances memory and protects against amnesia in rodent models. Brain and Cognition 2010, 74:1-9.
67. The rat brain in stereotaxic coordinates 1998, Acad Press, New York, p. 4. G. Paxinos, C. Watson (Eds.).
68. Pedersen P.L., Greenawalt J.W., Reynafarje B., Hullihen J., Decker G.L., Soper J.W., et al. Preparation and characterization of mitochondria and sub-mitochondrial particles of rat liver-derived tissues. Methods in Cell Biology 1978, 20:411-481.
69. Picard M., McEwen B.S. Mitochondria impact brain function and cognition. Proceedings of National Academy Science USA 2014, 111(1):7-8.
70. Pinho C.M., Teixeira P.F., Glaser E. Mitochondrial import and degradation of amyloid-β peptide. Biochimica et Biophysica Acta 2014, 1837(7):1069-1074.
71. Rezai-Zadeh K., Shytle D., Sun N., Mori T., Hou H., Jeanniton D., et al. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. Journal of Neuroscience 2005, 25:8807-8814.
72. Salamone F., Galvano F., Cappello F., Mangiameli A., Barbagallo I., Li Volti G. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. Translational Research 2012, 159:477-486.
73. Salamone F., Galvano F., Marino Gammazza A., Paternostro C., Tibullo D., Bucchieri F., et al. Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis. Digestive and Liver Disease 2012, 44:334-342.
74. Sally L.O., Margaret A.J. Methods of microphotometric assay of succinate dehydrogenase and cytochrome-C oxidase activities for use on human skeletal muscle. Histochemical Journal 1989, 21:545-555.
75. Sandhir R., Mehrotra A., Kamboj S.S. Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system. Neurochemistry International 2010, 57(5):579-587.
76. Shapiro B.L., Feigal R.J., Lam F.H. Mitochondrial NADH dehydrogenase in cystic fibrosis. Proceedings of the National academy of Sciences of the United States of America 1979, 76:2979-2983.
77. Shaw K.N., Commins S., O'Mara S.M. Lipopolysaccharide causes deficits in spatial learning in the water maze but not in bdnf expression in the rat dentate gyrus. Behavioural Brain Research 2001, 124:47-54.
78. Simic G., Lucassen P.J., Krsnik Z., Kruslin B., Kostovic I., Winblad B., et al. nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease. Experimental Neurology 2000, 165:12-26.
79. Storrie B., Madden E.A. Isolation of subcellular organelles. Methods in Enzymology 1990, 182:203-225.
80. Thinakaran G., Koo E.H. Amyloid precursor protein trafficking, processing, and function. Journal of Biological Chemistry 2008, 283:29615-29619.
81. Thomson L.M., Sutherland R.J. Systemic administration of lipopolysaccharide and interleukin-1beta have different effects on memory consolidation. Brain Research Bulletin 2005, 67:24-29.
82. Tomita S., Kirino Y., Suzuki T. Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosylation of APP in the protein secretory pathway. Identification of intracellular compartments in which APP cleavage occurs without using toxic agents that interfere with protein metabolism. Journal of Biological Chemistry 1998, 273:6277-6284.
83. Tota S., Kamat P.K., Shukla R., Nath C. Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment. Behavioural Brain Research 2011, 221:207-215.
84. Tyagi E., Agrawal R., Nath C., Shukla R. Effect of anti dementia drugs on LPS induced neuroinflammation in mice. Life Sciences 2007, 80:1977-1983.
85. Tyagi E., Agrawal R., Nath C., Shukla R. Influence of LPS-induced neuroinflammation on acetylcholinesterase activity in rat brain. Journal of Neuroimmunology 2008, 205:51-56.
86. Tyagi E., Agrawal R., Nath C., Shukla R. Effect of melatonin on neuroinflammation and acetylcholinesterase activity induced by LPS in rat brain. European Journal of Pharmacology 2010, 640(1-3):206-210.
87. Vegeto E., Bonincontro C., Pollio G., Sala A., Viappiani S., Nardi F., et al. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. Journal of Neuroscience 2001, 21:1809-1818.
88. Wang L.-Y., Niu Z.-z., Hu B.-x., Wu J.-m., Jiang X., Hu X.-f., et al. Long-term intraperitoneal injection of lipopolysaccharide induces high expression of Id2 in the brain of mice. Molecular Biology Reports 2011, 38:4193-4196.
89. Wang Q., Zou L., Liu W., Hao W., Tashiro S., Onodera S., et al. Inhibiting NF-κB activation and ROS production are involved in the mechanism of silibinin's protection against d-galactose-induced senescence. Pharmacology, Biochemistry and Behavior 2011, 98:140-149.
90. Wenk G.L., Rosi S., McGann K., Hauss-Wegrzyniak B. A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat. European Journal of Pharmacology 2002, 453:319-324.
91. Wyss-Coray T. Inflammation in Alzheimer disease: Driving force, bystander or beneficial response?. Nature Medicine 2006, 12:1005-1015.
92. Yun K.J., Shin J.S., Choi J.H., Back N.I., Chung H.G., Lee K.T. Quaternary alkaloid, pseudocoptisine isolated from tubers of Corydalis turtschaninovi inhibits LPS-induced nitric oxide, PGE(2), and pro-inflammatory cytokines production via the down-regulation of NF-kappaB in RAW 264.7 murine macrophage cells. International Immunopharmacology 2009, 9(11):1323-1331.
93. Zhang F., Qian L., Flood P.M., Shi J.S., Hong J.S., Gao H.M. Inhibition of IkappaB kinase-beta protects dopamine neurons against lipopolysaccharide induced neurotoxicity. Journal of Pharmacology and Experimental Therapeutics 2010, 333:822-833.
94. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469(7329):221-225.
95. Zoukhri D., Kublin C.L. Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome. Investigative Ophthalmology & Visual Science 2001, 42(5):925-932.